Mapfre, an international insurance company, has reached an agreement to acquire a 38.9% stake in Spanish insurtech Tuio, the specialist digital insurance distributor that leverages advanced technological capabilities and significant artificial intelligence (AI) maturity in its business model.
According to the announcement, the agreement will allow Tuio, which currently operates in Spain, to continue driving its capabilities and accelerate development of its advanced digital model into new markets across Latin America and Europe, where Mapfre already has a notable. presence.
As mentioned, Mapfre will acquire 38.9% of Tuio’s share capital, which will reportedly be structured through the direct purchase of shares from certain shareholders and subsequent participation in a capital increase.
Tuio was the first insurance app in the world to be integrated into ChatGPT for the sale of insurance products, and since its integration in early February, the company now reportedly generates more than 20% of its new clients through AI assistants.
Furthermore, both companies noted that the transaction reflects Mapfre’s conviction that AI, and notably agentic AI, represent a significant technological transformation for both the insurance sector and the wider digital economy.
As a result, this investment allows Mapfre to enhance its commitment to more agile and personalised distribution models that cater to emerging consumer demands, merging technological capabilities with the unique value of human guidance.
It’s also important to highlight that Mapfre’s purchase of a stake in Tuio amounts to a significant show of support for the company’s business project and underpins both its growth plans in Spain and its international expansion.
Both companies explained that the transaction “will accelerate development of new technological capabilities and consolidate Tuio’s expansion, while maintaining its principles of innovation, agility, and digital specialisation, which have characterised its evolution from day one.”
The transaction is subject to the regulatory authorisations that may apply.
